Medical News Summary: Alternative drug for type 2 diabetes awaiting FDA approval

About: Alternative drug for type 2 diabetes awaiting FDA approval
Date: 28 October 2004
Source: Reuters
Medical News Summary (summary of medical news story as reported by Reuters): Exenatide is waiting for approval by the FDA as an alternative diabetes drug for type 2 sufferers who don’t respond well to sulfonylurea-type drugs. The drug also promotes weight loss. The drug works by imitating intestinal tract hormones that help regulate glucose levels. The main side effects of the drug are mild to moderate nausea during initial stages of treatment.
URL: http://www.reuters.com/newsArticle.jhtml?type=healthNews&storyID=6649116
Related Disease Topics: Diabetes, Type 2 diabetes, Overweight
Related Symptom Topics: Nausea

---

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

• Medication
• medication and diabetes
• medication and type 2 diabetes
• Research
• research and diabetes

Medical Tools & Articles:

Next articles:

• Risk Factor Center
• Medical Statistics Center
• Medical Treatment Center
• Prevention Center
• Medical Tests Center

Medical Articles:

• Disease & Treatments Search
• Online Diagnosis
• Misdiagnosis Center
• Full list of interesting articles